ArticleFrontiers in immunology2025

Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study.

Aurora Zanghì et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.